Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$20.4 - $24.73 $540,661 - $655,419
26,503 New
26,503 $601,000
Q4 2020

Feb 12, 2021

SELL
$26.52 - $49.35 $962,941 - $1.79 Million
-36,310 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$27.01 - $40.26 $572,530 - $853,391
21,197 Added 140.26%
36,310 $999,000
Q2 2020

Aug 04, 2020

BUY
$27.75 - $43.44 $419,385 - $656,508
15,113 New
15,113 $557,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $458M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.